Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of 'spacer DNA' from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
According to APO Research, The global CRISPR and CRISPR-Associated (Cas) Genes market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for CRISPR and CRISPR-Associated (Cas) Genes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for CRISPR and CRISPR-Associated (Cas) Genes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for CRISPR and CRISPR-Associated (Cas) Genes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of CRISPR and CRISPR-Associated (Cas) Genes include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich and Precision Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CRISPR and CRISPR-Associated (Cas) Genes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR and CRISPR-Associated (Cas) Genes.
The CRISPR and CRISPR-Associated (Cas) Genes market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR and CRISPR-Associated (Cas) Genes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRISPR and CRISPR-Associated (Cas) Genes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CRISPR and CRISPR-Associated (Cas) Genes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRISPR and CRISPR-Associated (Cas) Genes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of CRISPR and CRISPR-Associated (Cas) Genes companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of 'spacer DNA' from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
According to APO Research, The global CRISPR and CRISPR-Associated (Cas) Genes market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for CRISPR and CRISPR-Associated (Cas) Genes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for CRISPR and CRISPR-Associated (Cas) Genes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for CRISPR and CRISPR-Associated (Cas) Genes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of CRISPR and CRISPR-Associated (Cas) Genes include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich and Precision Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CRISPR and CRISPR-Associated (Cas) Genes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR and CRISPR-Associated (Cas) Genes.
The CRISPR and CRISPR-Associated (Cas) Genes market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR and CRISPR-Associated (Cas) Genes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Thermo Fisher Scientific
- Editas Medicine
- Caribou Biosciences
- CRISPR therapeutics
- Intellia therapeutics, Inc.
- Cellectis
- Horizon Discovery Plc
- Sigma Aldrich
- Precision Biosciences
- Genscript
- Sangamo Biosciences Inc.
- Lonza Group Limited
- Integrated DNA Technologies
- New England Biolabs
- Origene Technologies
- Genome Editing
- Genetic engineering
- gRNA Database/Gene Librar
- CRISPR Plasmid
- Human Stem Cells
- Genetically Modified Organisms/Crops
- Cell Line Engineering
- Biotechnology Companies
- Pharmaceutical Companies
- Academic Institutes
- Research and Development Institutes
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRISPR and CRISPR-Associated (Cas) Genes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CRISPR and CRISPR-Associated (Cas) Genes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRISPR and CRISPR-Associated (Cas) Genes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of CRISPR and CRISPR-Associated (Cas) Genes companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2019-2030)
1.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2019-2024)
1.4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2025-2030)
1.5 Key Regions CRISPR and CRISPR-Associated (Cas) Genes Market Size (2019-2030)
1.5.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030)
1.5.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030)
1.5.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030)
2 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET BY TYPE
2.1 Type Introduction
2.1.1 Genome Editing
2.1.2 Genetic engineering
2.1.3 gRNA Database/Gene Librar
2.1.4 CRISPR Plasmid
2.1.5 Human Stem Cells
2.1.6 Genetically Modified Organisms/Crops
2.1.7 Cell Line Engineering
2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
2.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Overview by Type (2019-2030)
2.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size Review by Type (2019-2024)
2.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecasted by Type (2025-2030)
2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Regions
2.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024)
2.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024)
3 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Biotechnology Companies
3.1.2 Pharmaceutical Companies
3.1.3 Academic Institutes
3.1.4 Research and Development Institutes
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
3.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Overview by Application (2019-2030)
3.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size Review by Application (2019-2024)
3.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecasted by Application (2025-2030)
3.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Regions
3.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024)
3.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
4.2 CRISPR and CRISPR-Associated (Cas) Genes Industry Drivers
4.3 CRISPR and CRISPR-Associated (Cas) Genes Industry Opportunities and Challenges
4.4 CRISPR and CRISPR-Associated (Cas) Genes Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by CRISPR and CRISPR-Associated (Cas) Genes Revenue (2019-2024)
5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global CRISPR and CRISPR-Associated (Cas) Genes Key Company Headquarters & Area Served
5.4 Global CRISPR and CRISPR-Associated (Cas) Genes Company, Product Type & Application
5.5 Global CRISPR and CRISPR-Associated (Cas) Genes Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market CR5 and HHI
5.6.2 Global Top 5 and 10 CRISPR and CRISPR-Associated (Cas) Genes Players Market Share by Revenue in 2023
5.6.3 2023 CRISPR and CRISPR-Associated (Cas) Genes Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Comapny Information
6.1.2 Thermo Fisher Scientific Business Overview
6.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments
6.2 Editas Medicine
6.2.1 Editas Medicine Comapny Information
6.2.2 Editas Medicine Business Overview
6.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.2.5 Editas Medicine Recent Developments
6.3 Caribou Biosciences
6.3.1 Caribou Biosciences Comapny Information
6.3.2 Caribou Biosciences Business Overview
6.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.3.5 Caribou Biosciences Recent Developments
6.4 CRISPR therapeutics
6.4.1 CRISPR therapeutics Comapny Information
6.4.2 CRISPR therapeutics Business Overview
6.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.4.5 CRISPR therapeutics Recent Developments
6.5 Intellia therapeutics, Inc.
6.5.1 Intellia therapeutics, Inc. Comapny Information
6.5.2 Intellia therapeutics, Inc. Business Overview
6.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.5.5 Intellia therapeutics, Inc. Recent Developments
6.6 Cellectis
6.6.1 Cellectis Comapny Information
6.6.2 Cellectis Business Overview
6.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.6.5 Cellectis Recent Developments
6.7 Horizon Discovery Plc
6.7.1 Horizon Discovery Plc Comapny Information
6.7.2 Horizon Discovery Plc Business Overview
6.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.7.5 Horizon Discovery Plc Recent Developments
6.8 Sigma Aldrich
6.8.1 Sigma Aldrich Comapny Information
6.8.2 Sigma Aldrich Business Overview
6.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.8.5 Sigma Aldrich Recent Developments
6.9 Precision Biosciences
6.9.1 Precision Biosciences Comapny Information
6.9.2 Precision Biosciences Business Overview
6.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.9.5 Precision Biosciences Recent Developments
6.10 Genscript
6.10.1 Genscript Comapny Information
6.10.2 Genscript Business Overview
6.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.10.5 Genscript Recent Developments
6.11 Sangamo Biosciences Inc.
6.11.1 Sangamo Biosciences Inc. Comapny Information
6.11.2 Sangamo Biosciences Inc. Business Overview
6.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.11.5 Sangamo Biosciences Inc. Recent Developments
6.12 Lonza Group Limited
6.12.1 Lonza Group Limited Comapny Information
6.12.2 Lonza Group Limited Business Overview
6.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.12.5 Lonza Group Limited Recent Developments
6.13 Integrated DNA Technologies
6.13.1 Integrated DNA Technologies Comapny Information
6.13.2 Integrated DNA Technologies Business Overview
6.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.13.5 Integrated DNA Technologies Recent Developments
6.14 New England Biolabs
6.14.1 New England Biolabs Comapny Information
6.14.2 New England Biolabs Business Overview
6.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.14.5 New England Biolabs Recent Developments
6.15 Origene Technologies
6.15.1 Origene Technologies Comapny Information
6.15.2 Origene Technologies Business Overview
6.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.15.4 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.15.5 Origene Technologies Recent Developments
7 NORTH AMERICA
7.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024)
7.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024)
8.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024)
9.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024)
10.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024)
11.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2019-2030)
1.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2019-2024)
1.4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2025-2030)
1.5 Key Regions CRISPR and CRISPR-Associated (Cas) Genes Market Size (2019-2030)
1.5.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030)
1.5.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030)
1.5.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030)
2 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET BY TYPE
2.1 Type Introduction
2.1.1 Genome Editing
2.1.2 Genetic engineering
2.1.3 gRNA Database/Gene Librar
2.1.4 CRISPR Plasmid
2.1.5 Human Stem Cells
2.1.6 Genetically Modified Organisms/Crops
2.1.7 Cell Line Engineering
2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
2.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Overview by Type (2019-2030)
2.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size Review by Type (2019-2024)
2.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecasted by Type (2025-2030)
2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Regions
2.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024)
2.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024)
3 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Biotechnology Companies
3.1.2 Pharmaceutical Companies
3.1.3 Academic Institutes
3.1.4 Research and Development Institutes
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
3.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Overview by Application (2019-2030)
3.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size Review by Application (2019-2024)
3.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecasted by Application (2025-2030)
3.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Regions
3.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024)
3.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
4.2 CRISPR and CRISPR-Associated (Cas) Genes Industry Drivers
4.3 CRISPR and CRISPR-Associated (Cas) Genes Industry Opportunities and Challenges
4.4 CRISPR and CRISPR-Associated (Cas) Genes Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by CRISPR and CRISPR-Associated (Cas) Genes Revenue (2019-2024)
5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global CRISPR and CRISPR-Associated (Cas) Genes Key Company Headquarters & Area Served
5.4 Global CRISPR and CRISPR-Associated (Cas) Genes Company, Product Type & Application
5.5 Global CRISPR and CRISPR-Associated (Cas) Genes Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market CR5 and HHI
5.6.2 Global Top 5 and 10 CRISPR and CRISPR-Associated (Cas) Genes Players Market Share by Revenue in 2023
5.6.3 2023 CRISPR and CRISPR-Associated (Cas) Genes Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Comapny Information
6.1.2 Thermo Fisher Scientific Business Overview
6.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments
6.2 Editas Medicine
6.2.1 Editas Medicine Comapny Information
6.2.2 Editas Medicine Business Overview
6.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.2.5 Editas Medicine Recent Developments
6.3 Caribou Biosciences
6.3.1 Caribou Biosciences Comapny Information
6.3.2 Caribou Biosciences Business Overview
6.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.3.5 Caribou Biosciences Recent Developments
6.4 CRISPR therapeutics
6.4.1 CRISPR therapeutics Comapny Information
6.4.2 CRISPR therapeutics Business Overview
6.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.4.5 CRISPR therapeutics Recent Developments
6.5 Intellia therapeutics, Inc.
6.5.1 Intellia therapeutics, Inc. Comapny Information
6.5.2 Intellia therapeutics, Inc. Business Overview
6.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.5.5 Intellia therapeutics, Inc. Recent Developments
6.6 Cellectis
6.6.1 Cellectis Comapny Information
6.6.2 Cellectis Business Overview
6.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.6.5 Cellectis Recent Developments
6.7 Horizon Discovery Plc
6.7.1 Horizon Discovery Plc Comapny Information
6.7.2 Horizon Discovery Plc Business Overview
6.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.7.5 Horizon Discovery Plc Recent Developments
6.8 Sigma Aldrich
6.8.1 Sigma Aldrich Comapny Information
6.8.2 Sigma Aldrich Business Overview
6.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.8.5 Sigma Aldrich Recent Developments
6.9 Precision Biosciences
6.9.1 Precision Biosciences Comapny Information
6.9.2 Precision Biosciences Business Overview
6.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.9.5 Precision Biosciences Recent Developments
6.10 Genscript
6.10.1 Genscript Comapny Information
6.10.2 Genscript Business Overview
6.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.10.5 Genscript Recent Developments
6.11 Sangamo Biosciences Inc.
6.11.1 Sangamo Biosciences Inc. Comapny Information
6.11.2 Sangamo Biosciences Inc. Business Overview
6.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.11.5 Sangamo Biosciences Inc. Recent Developments
6.12 Lonza Group Limited
6.12.1 Lonza Group Limited Comapny Information
6.12.2 Lonza Group Limited Business Overview
6.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.12.5 Lonza Group Limited Recent Developments
6.13 Integrated DNA Technologies
6.13.1 Integrated DNA Technologies Comapny Information
6.13.2 Integrated DNA Technologies Business Overview
6.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.13.5 Integrated DNA Technologies Recent Developments
6.14 New England Biolabs
6.14.1 New England Biolabs Comapny Information
6.14.2 New England Biolabs Business Overview
6.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.14.5 New England Biolabs Recent Developments
6.15 Origene Technologies
6.15.1 Origene Technologies Comapny Information
6.15.2 Origene Technologies Business Overview
6.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Global Share and Gross Margin (2019-2024)
6.15.4 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
6.15.5 Origene Technologies Recent Developments
7 NORTH AMERICA
7.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024)
7.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024)
8.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024)
9.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024)
10.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024)
11.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
LIST OF TABLES
Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2019-2024)
Table 4. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2025-2030)
Table 6. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Type (2019-2024)
Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Share Forecasted by Type (2025-2030)
Table 11. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Application (2019-2024)
Table 24. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Share Forecasted by Application (2025-2030)
Table 26. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
Table 37. CRISPR and CRISPR-Associated (Cas) Genes Industry Drivers
Table 38. CRISPR and CRISPR-Associated (Cas) Genes Industry Opportunities and Challenges
Table 39. CRISPR and CRISPR-Associated (Cas) Genes Industry Restraints
Table 40. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2019-2024)
Table 42. Global CRISPR and CRISPR-Associated (Cas) Genes Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global CRISPR and CRISPR-Associated (Cas) Genes Key Company Headquarters & Area Served
Table 44. Global CRISPR and CRISPR-Associated (Cas) Genes Company, Product Type & Application
Table 45. Global CRISPR and CRISPR-Associated (Cas) Genes Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global CRISPR and CRISPR-Associated (Cas) Genes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 51. Thermo Fisher Scientific Recent Development
Table 52. Editas Medicine Company Information
Table 53. Editas Medicine Business Overview
Table 54. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 56. Editas Medicine Recent Development
Table 57. Caribou Biosciences Company Information
Table 58. Caribou Biosciences Business Overview
Table 59. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 61. Caribou Biosciences Recent Development
Table 62. CRISPR therapeutics Company Information
Table 63. CRISPR therapeutics Business Overview
Table 64. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 66. CRISPR therapeutics Recent Development
Table 67. Intellia therapeutics, Inc. Company Information
Table 68. Intellia therapeutics, Inc. Business Overview
Table 69. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 71. Intellia therapeutics, Inc. Recent Development
Table 72. Cellectis Company Information
Table 73. Cellectis Business Overview
Table 74. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 76. Cellectis Recent Development
Table 77. Horizon Discovery Plc Company Information
Table 78. Horizon Discovery Plc Business Overview
Table 79. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 81. Horizon Discovery Plc Recent Development
Table 82. Sigma Aldrich Company Information
Table 83. Sigma Aldrich Business Overview
Table 84. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 86. Sigma Aldrich Recent Development
Table 87. Precision Biosciences Company Information
Table 88. Precision Biosciences Business Overview
Table 89. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 91. Precision Biosciences Recent Development
Table 92. Genscript Company Information
Table 93. Genscript Business Overview
Table 94. Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 96. Genscript Recent Development
Table 97. Sangamo Biosciences Inc. Company Information
Table 98. Sangamo Biosciences Inc. Business Overview
Table 99. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 101. Sangamo Biosciences Inc. Recent Development
Table 102. Lonza Group Limited Company Information
Table 103. Lonza Group Limited Business Overview
Table 104. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 105. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 106. Lonza Group Limited Recent Development
Table 107. Integrated DNA Technologies Company Information
Table 108. Integrated DNA Technologies Business Overview
Table 109. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 110. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 111. Integrated DNA Technologies Recent Development
Table 112. New England Biolabs Company Information
Table 113. New England Biolabs Business Overview
Table 114. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 115. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 116. New England Biolabs Recent Development
Table 117. Origene Technologies Company Information
Table 118. Origene Technologies Business Overview
Table 119. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 120. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 121. Origene Technologies Recent Development
Table 122. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 123. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024) & (US$ Million)
Table 124. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2019-2024)
Table 125. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 126. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Country (2025-2030)
Table 127. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 128. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024) & (US$ Million)
Table 129. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2019-2024)
Table 130. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 131. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Country (2025-2030)
Table 132. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 133. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024) & (US$ Million)
Table 134. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2019-2024)
Table 135. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 136. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Country (2025-2030)
Table 137. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 138. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024) & (US$ Million)
Table 139. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2019-2024)
Table 140. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 141. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Country (2025-2030)
Table 142. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 143. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024) & (US$ Million)
Table 144. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2019-2024)
Table 145. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 146. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Country (2025-2030)
Table 147. Research Programs/Design for This Report
Table 148. Authors List of This Report
Table 149. Secondary Sources
Table 150. Primary Sources
Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2019-2024)
Table 4. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2025-2030)
Table 6. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Type (2019-2024)
Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Share Forecasted by Type (2025-2030)
Table 11. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Application (2019-2024)
Table 24. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Share Forecasted by Application (2025-2030)
Table 26. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
Table 37. CRISPR and CRISPR-Associated (Cas) Genes Industry Drivers
Table 38. CRISPR and CRISPR-Associated (Cas) Genes Industry Opportunities and Challenges
Table 39. CRISPR and CRISPR-Associated (Cas) Genes Industry Restraints
Table 40. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2019-2024)
Table 42. Global CRISPR and CRISPR-Associated (Cas) Genes Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global CRISPR and CRISPR-Associated (Cas) Genes Key Company Headquarters & Area Served
Table 44. Global CRISPR and CRISPR-Associated (Cas) Genes Company, Product Type & Application
Table 45. Global CRISPR and CRISPR-Associated (Cas) Genes Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global CRISPR and CRISPR-Associated (Cas) Genes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 51. Thermo Fisher Scientific Recent Development
Table 52. Editas Medicine Company Information
Table 53. Editas Medicine Business Overview
Table 54. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 56. Editas Medicine Recent Development
Table 57. Caribou Biosciences Company Information
Table 58. Caribou Biosciences Business Overview
Table 59. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 61. Caribou Biosciences Recent Development
Table 62. CRISPR therapeutics Company Information
Table 63. CRISPR therapeutics Business Overview
Table 64. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 66. CRISPR therapeutics Recent Development
Table 67. Intellia therapeutics, Inc. Company Information
Table 68. Intellia therapeutics, Inc. Business Overview
Table 69. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 71. Intellia therapeutics, Inc. Recent Development
Table 72. Cellectis Company Information
Table 73. Cellectis Business Overview
Table 74. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 76. Cellectis Recent Development
Table 77. Horizon Discovery Plc Company Information
Table 78. Horizon Discovery Plc Business Overview
Table 79. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 81. Horizon Discovery Plc Recent Development
Table 82. Sigma Aldrich Company Information
Table 83. Sigma Aldrich Business Overview
Table 84. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 86. Sigma Aldrich Recent Development
Table 87. Precision Biosciences Company Information
Table 88. Precision Biosciences Business Overview
Table 89. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 91. Precision Biosciences Recent Development
Table 92. Genscript Company Information
Table 93. Genscript Business Overview
Table 94. Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 96. Genscript Recent Development
Table 97. Sangamo Biosciences Inc. Company Information
Table 98. Sangamo Biosciences Inc. Business Overview
Table 99. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 101. Sangamo Biosciences Inc. Recent Development
Table 102. Lonza Group Limited Company Information
Table 103. Lonza Group Limited Business Overview
Table 104. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 105. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 106. Lonza Group Limited Recent Development
Table 107. Integrated DNA Technologies Company Information
Table 108. Integrated DNA Technologies Business Overview
Table 109. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 110. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 111. Integrated DNA Technologies Recent Development
Table 112. New England Biolabs Company Information
Table 113. New England Biolabs Business Overview
Table 114. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 115. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 116. New England Biolabs Recent Development
Table 117. Origene Technologies Company Information
Table 118. Origene Technologies Business Overview
Table 119. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 120. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Portfolio
Table 121. Origene Technologies Recent Development
Table 122. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 123. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024) & (US$ Million)
Table 124. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2019-2024)
Table 125. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 126. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Country (2025-2030)
Table 127. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 128. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024) & (US$ Million)
Table 129. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2019-2024)
Table 130. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 131. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Country (2025-2030)
Table 132. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 133. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024) & (US$ Million)
Table 134. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2019-2024)
Table 135. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 136. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Country (2025-2030)
Table 137. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 138. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024) & (US$ Million)
Table 139. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2019-2024)
Table 140. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 141. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Country (2025-2030)
Table 142. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 143. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2019-2024) & (US$ Million)
Table 144. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2019-2024)
Table 145. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 146. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Country (2025-2030)
Table 147. Research Programs/Design for This Report
Table 148. Authors List of This Report
Table 149. Secondary Sources
Table 150. Primary Sources
LIST OF FIGURES
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Product Picture
Figure 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (2019-2030) & (US$ Million)
Figure 4. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region: 2023 VS 2030
Figure 5. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2019-2030)
Figure 6. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Genome Editing
Figure 12. Global Genome Editing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Genetic engineering
Figure 14. Global Genetic engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of gRNA Database/Gene Librar
Figure 16. Global gRNA Database/Gene Librar Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Product Picture of CRISPR Plasmid
Figure 18. Global CRISPR Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Product Picture of Human Stem Cells
Figure 20. Global Human Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Product Picture of Genetically Modified Organisms/Crops
Figure 22. Global Genetically Modified Organisms/Crops Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Product Picture of Cell Line Engineering
Figure 24. Global Cell Line Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 26. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type 2023 VS 2030
Figure 27. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Type (2019-2030)
Figure 28. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Type (2019-2030)
Figure 29. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Type (2019-2030)
Figure 30. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Type (2019-2030)
Figure 31. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Type (2019-2030)
Figure 32. Product Picture of Biotechnology Companies
Figure 33. Global Biotechnology Companies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Product Picture of Pharmaceutical Companies
Figure 35. Global Pharmaceutical Companies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Product Picture of Academic Institutes
Figure 37. Global Academic Institutes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Product Picture of Research and Development Institutes
Figure 39. Global Research and Development Institutes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 41. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application 2023 VS 2030
Figure 42. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Application (2019-2030)
Figure 43. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Application (2019-2030)
Figure 44. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Application (2019-2030)
Figure 45. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Application (2019-2030)
Figure 46. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Application (2019-2030)
Figure 47. Global Top 5 and 10 CRISPR and CRISPR-Associated (Cas) Genes Players Market Share by Revenue in 2023
Figure 48. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 49. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country: 2019 VS 2023 VS 2030
Figure 51. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Product Picture
Figure 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (2019-2030) & (US$ Million)
Figure 4. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region: 2023 VS 2030
Figure 5. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2019-2030)
Figure 6. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Genome Editing
Figure 12. Global Genome Editing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Genetic engineering
Figure 14. Global Genetic engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of gRNA Database/Gene Librar
Figure 16. Global gRNA Database/Gene Librar Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Product Picture of CRISPR Plasmid
Figure 18. Global CRISPR Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Product Picture of Human Stem Cells
Figure 20. Global Human Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Product Picture of Genetically Modified Organisms/Crops
Figure 22. Global Genetically Modified Organisms/Crops Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Product Picture of Cell Line Engineering
Figure 24. Global Cell Line Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 26. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type 2023 VS 2030
Figure 27. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Type (2019-2030)
Figure 28. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Type (2019-2030)
Figure 29. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Type (2019-2030)
Figure 30. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Type (2019-2030)
Figure 31. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Type (2019-2030)
Figure 32. Product Picture of Biotechnology Companies
Figure 33. Global Biotechnology Companies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Product Picture of Pharmaceutical Companies
Figure 35. Global Pharmaceutical Companies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Product Picture of Academic Institutes
Figure 37. Global Academic Institutes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Product Picture of Research and Development Institutes
Figure 39. Global Research and Development Institutes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 41. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application 2023 VS 2030
Figure 42. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Application (2019-2030)
Figure 43. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Application (2019-2030)
Figure 44. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Application (2019-2030)
Figure 45. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Application (2019-2030)
Figure 46. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Application (2019-2030)
Figure 47. Global Top 5 and 10 CRISPR and CRISPR-Associated (Cas) Genes Players Market Share by Revenue in 2023
Figure 48. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 49. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country: 2019 VS 2023 VS 2030
Figure 51. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share
